Hawaiian Eye & Retina Meeting

CME INFORMATION

RETINA PROGRAM
Evaluations and CME Certificates

2021 evaluations are available HERE through June 14, 2021 (your username is your email and the password is "Maui21"). Please email evals@HealioLive.com if you need assistance with this year’s credits or cme@VindicoMedEd.com if you need a certificate from a previous year.

Target Audience

The intended audience for this activity is retina specialists and other health care professionals involved in the management of patients with retinal disease.

Program Summary

This program is designed by and for retina specialists, offering updates on the most recent advances and their integration into everyday practice as well as insight into varying challenges, including the implementation of new diagnostic and treatment modalities. In a relaxed setting, faculty and attendees can discuss specific cases, new therapy and imaging technologies and the latest surgical strategies. This program offers an unopposed schedule including: General sessions, seminars, workshops, banyan tree sessions, exhibit hall breaks and special events (all included in the single registration fee except the luau). Retina Program attendees are also able to attend sessions of interest under the Hawaiian Eye Comprehensive Ophthalmologist Program.

Learning Objectives: General Sessions (Monday to Friday)

Upon completion of this activity, attendees will have better knowledge of the following subject matters:

  • Describe the use of machine learning to enhance diagnostic capabilities.
  • Assess tips and tricks for the use of multimodal imaging in the management of uveitis
  • Explore the use of OCT and OCTA in the management of macular disease.
  • Review complement modulation techniques in the management of dry age-related macular degeneration (AMD)
  • Evaluate new pathways in the management of retinal vascular diseases.
  • Compare the efficacy, safety, and durability of current wet AMD treatments.
  • Determine the best treatment strategies to maximize long-term vision outcomes in patients with wet AMD.
  • Recognize the unmet needs in managing dry and wet AMD.
  • Assess the potential role of future wet AMD treatments.
  • Evaluate the latest clinical trial results for emerging geographic atrophy therapies.
  • Summarize new concepts in the pathogenesis of diabetic retinopathy.
  • Assess new imaging technologies for their ability to better manage and classify retinal vascular disease.
  • Examine an evidenced-based approach for the management of retinal vascular disease.
  • Evaluate the latest clinical trial results for retinal vascular disease.
  • Describe best practices for eyes with proliferative diabetic retinopathy (PDR) that require surgical management.
  • Summarize current knowledge about the management of pediatric retinal disorders, uveitis, and posterior pole tumors.
  • Review the utility of multimodal imaging in pediatric retinal disorders and posterior pole tumors.
  • Examine current management strategies for pediatric retinal detachment.
  • Assess challenging cases and clinical pearls for the diagnosis of white dot retinal disorders and uveitis
  • Review current and early phase management strategies for ocular tumors
  • Explore current insights and practical considerations in the management of inherited retinal diseases.
  • Describe techniques that may improve outcomes in patients undergoing macular surgery.
  • Assess new instrumentation utilized in vitreoretinal surgery.
  • Examine controversies in the management of retinal detachment.

This continuing medical education activity is provided by

ACCREDITATION: Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 35.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INTERNATIONAL NOTICE: This educational activity is designated for AMA PRA Category 1 Credit(s)™ for all US physicians. US physicians will receive a CME certificate and non-US physicians should contact their respective organizations for reciprocity of credit.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to mitigate and disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.